Evaluation of the Bioequivalence of Sprinkle and Capsule Formulations of Lubiprostone, as Compared to Placebo
Status:
Completed
Trial end date:
2017-08-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the bioequivalence of sprinkle and capsule
formulations of lubiprostone, as compared to placebo, when administered orally in
participants with Chronic Idiopathic Constipation (CIC).